Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
- Conditions
- Vaginal InfectionVaginitis
- Registration Number
- NCT05557318
- Lead Sponsor
- Taiwan Carbon Nano Technology Corporation
- Brief Summary
This clinical study aims to train the algorithm and assess the performance of the Ainos Flora Women's Vaginal Health Tester in identifying vaginal infections.
- Detailed Description
Ainos Flora Women's Vaginal Health Tester is an in vitro diagnostic device implementing electronic nose technology to detect vaginal infections by examining metabolized gases of vaginal bacteria. The electronic nose system mainly comprises the Micro-Electro-Mechanical Systems (MEMS) gas sensor array and the Artificial Neural Network algorithm. The primary purpose of this study is to train the algorithm and assess the performance of the Ainos Flora in identifying vaginal infections. In addition, the primary outcome measures of this study, including sensitivity and specificity, will be used as a reference for the feasibility and sample size assessment of the next phase of pivotal clinical trials.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 120
- Female, Age ≥20 to ≤50.
- Have had sexual experience.
- Fully understand the subject's informed consent process and be willing to undergo all study-related assessments and procedures.
Women who meet any of the following criteria by participant report will be excluded from the study:
- During menstruation.
- Have performed vaginal washing within three days.
- Have been treated for vaginal infections within one week.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method To assess the sensitivity and specificity of Ainos Flora in subjects compared to RT-PCR and culture groups in identifying the types of vaginitis. Up to 6 months. * Bacterial infection : Bacterial vaginosis (BV) / Escherichia coli / Trichomonas / Group B streptococcus / Chlamydia trachomatis / Neisseria gonorrhea
* Fungal infection: Candida albicans
* Mixed infection: Bacterial and fungal infections coexist
* No infection: Healthy participant
- Secondary Outcome Measures
Name Time Method Assess the change in specificity as the number of subjects is changed. Up to 6 months. When the number of subjects reaches 30,60,90,120, input the collected gas data into the algorithm and calculate the specificity. We can then assess the change in specificity when the number of subjects changes from 30 to 60, 90, and 120.
Assess the change in sensitivity as the number of subjects is changed. Up to 6 months. When the number of subjects reaches 30,60,90,120, input the collected gas data into the algorithm and calculate the sensitivity. We can then assess the change in sensitivity when the number of subjects changes from 30 to 60, 90, and 120.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
MacKay Memorial Hospital
🇨🇳Taipei, Taiwan
Tri-Service General Hospital
🇨🇳Taipei, Taiwan
MacKay Memorial Hospital🇨🇳Taipei, TaiwanDr. Wen-Chu HuangPrincipal InvestigatorDr. Chia-Sui WengSub Investigator